Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) and MSSA strains were treated with: (a) grapefruit oil (GFO) components, isolated by chromatography and characterised by NMR and mass spectroscopy; (b) antimicrobial agents, or (c) a combination of both to evaluate (MIC determination) intrinsic antibacterial activity and to determine whether GFO components could modulate bacterial sensitivity to the anti-bacterial agents. Preliminary data suggested that the grapefruit component 4-[[(E)-5-(3,3-dimethyl-2-oxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g]chromen-7-one (2) enhances the susceptibility of test MRSA strains to agents, e.g., ethidium bromide and norfloxacin, to which these micro-organisms are normally resistant.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Benzopyrans / isolation & purification
-
Citrus paradisi / chemistry*
-
Ethidium / pharmacology
-
Magnetic Resonance Spectroscopy
-
Mass Spectrometry
-
Membrane Transport Proteins / drug effects*
-
Methicillin Resistance
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Norfloxacin / pharmacology
-
Plant Oils / chemistry*
-
Plant Oils / pharmacology*
-
Staphylococcus aureus / drug effects*
Substances
-
4-(((E)-5-(3,3-diemthyl-2-oxiranyl)-3-mehtyl-2-pentenyl)oxy)-7H-furo(3,2-g)chromen-7-one
-
4-(((E)-5-(3,3-dimethyl-2-oxiranyl)-3-methyl-2-pentenyl)oxy)-7H-furo(3,2-g)chromen-7-one
-
7-(((2E)-3,7-dimethyl-2,6-octadienyl)oxy)-2H-2chromenone
-
Anti-Bacterial Agents
-
Benzopyrans
-
Membrane Transport Proteins
-
Plant Oils
-
Ethidium
-
Norfloxacin